Stock Events

Stock Events

Nexstim 

€9
0
+€0.17+1.93% Friday 15:32

Statistics

Day High
9
Day Low
8.92
52W High
16.15
52W Low
6.66
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

26FebExpected
Q4 2025
0.13
0.46
0.79
1.13
Expected EPS
0.1282625331626556
Actual EPS
0.1282625331626556

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 5NX.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Nemaura Medical
NMRD
Mkt Cap8,070
Nemaura Medical Inc. competes with Nexstim in the development of medical devices for the healthcare sector, focusing on diabetes management which overlaps with Nexstim's focus on therapeutic and diagnostic medical devices.
Neogen
NEOG
Mkt Cap2.05B
Neogen Corporation offers products for food and animal safety testing, which indirectly competes with Nexstim's focus on innovative health technologies and diagnostics.
Masimo
MASI
Mkt Cap9.59B
Masimo Corporation specializes in non-invasive patient monitoring technologies, competing with Nexstim's non-invasive brain health diagnostics and therapies.
Inogen
INGN
Mkt Cap173.2M
Inogen, Inc. provides portable oxygen concentrators for patients requiring respiratory therapy, indirectly competing with Nexstim's therapeutic devices in the broader healthcare equipment sector.
Medtronic
MDT
Mkt Cap111.22B
Medtronic plc offers medical technologies, services, and solutions, including neuromodulation devices that compete with Nexstim's navigated brain stimulation technology for therapeutic uses.
Boston Scientific
BSX
Mkt Cap93.36B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, competing with Nexstim in the neuromodulation and neurostimulation device market.
Abbvie
ABBV
Mkt Cap369.39B
AbbVie Inc. focuses on pharmaceuticals for central nervous system disorders among other areas, competing with Nexstim's non-drug therapies for similar conditions.
Stryker
SYK
Mkt Cap126.97B
Stryker Corporation specializes in medical technologies, including neurotechnology and spine products, directly competing with Nexstim's offerings in the neurostimulation and neuromodulation market.

About

Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company offers non-invasive brain stimulation technology for navigated transcranial magnetic stimulation (nTMS), including Navigated Brain Stimulation (NBS) system 6 for presurgical mapping of the speech and motor cortices of the brain, for the treatment of major depression and chronic unilateral neuropathic pain, and post-operative rehabilitation of motor deficits of the upper limb. The company markets and sells its diagnostics systems to universities and teaching hospitals. It has an exclusive collaboration with Sinaptica Therapeutics, Inc. for the development, manufacture, and delivery of precision neuromodulation system for the treatment of Alzheimer's disease and mild cognitive impairment; and a development and distribution collaboration with Brainlab AG for motor and speech mapping systems. The company was incorporated in 2000 and is headquartered in Helsinki, Finland.
Show more...
CEO
Mr. Mikko Karvinen
Employees
40
Country
Germany
ISIN
FI4000506811

Listings

MU
DE
5NX.MU
STU
DE
5NX.STU
F
DE
5NX.F
HE
FI
NXTMH.HE

0 Comments

Share your thoughts

FAQ

What is Nexstim stock price today?▼
The current price of 5NX.STU is €9 EUR — it has increased by +1.93% in the past 24 hours. Watch Nexstim stock price performance more closely on the chart.
What is Nexstim stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Nexstim stocks are traded under the ticker 5NX.STU.
Is Nexstim stock price growing?▼
5NX.STU stock has risen by +1.58% compared to the previous week, the month change is a +4.17% rise, over the last year Nexstim has showed a +16.28% increase.
When is the next Nexstim earnings date?▼
Nexstim is going to release the next earnings report on August 14, 2026.
What were Nexstim earnings last quarter?▼
5NX.STU earnings for the last quarter are 0.13 EUR per share, whereas the estimation was 0.13 EUR resulting in a +0% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Nexstim have?▼
As of April 12, 2026, the company has 40 employees.
In which sector is Nexstim located?▼
Nexstim operates in the Health & Wellness sector.
When did Nexstim complete a stock split?▼
Nexstim has not had any recent stock splits.
Where is Nexstim headquartered?▼
Nexstim is headquartered in Helsinki, Germany.